According to the Zhitong Finance App, Peijia Medical-B (09996.HK) announced 2026 interim results, with revenue of 425 million yuan, up 20.1% year on year; gross profit of 290 million yuan, up 17.13% year on year; and R&D expenditure of 884.09 million yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.